Novo Nordisk
NVO
#109
Rank
S$213.72 B
Marketcap
S$48.08
Share price
0.83%
Change (1 day)
-59.48%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): S$26.82 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are S$47.70 Billion. , an increase over its 2024 earnings that were of S$24.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 S$26.30 B9.13%
2024 S$24.10 B22.84%
2023 S$19.61 B57.81%
2022 S$12.43 B5.24%
2021 S$11.81 B12.38%
2020 S$10.51 B13.11%
2019 S$9.29 B-3.45%
2018 S$9.62 B1.88%
2017 S$9.44 B4.3%
2016 S$9.05 B10.32%
2015 S$8.21 B7.47%
2014 S$7.64 B3.4%
2013 S$7.38 B19.09%
2012 S$6.20 B15.58%
2011 S$5.36 B16.58%
2010 S$4.60 B25.66%
2009 S$3.66 B10.68%
2008 S$3.31 B55.82%
2007 S$2.12 B7.02%
2006 S$1.98 B19.05%
2005 S$1.66 B10.55%
2004 S$1.50 B
2002 S$1.06 B-14.39%
2001 S$1.23 B-52.82%
2000 S$2.62 B250%
1999 S$0.75 B31.21%
1998 S$0.57 B34.31%
1997 S$0.42 B11.46%
1996 S$0.38 B9.03%
1995 S$0.35 B-3.15%
1994 S$0.36 B-0.67%
1993 S$0.36 B45.38%
1992 S$0.25 B-13.81%
1991 S$0.29 B37.12%
1990 S$0.21 B-0.79%
1989 S$0.21 B26.2%
1988 S$0.16 B24.97%
1987 S$0.13 B-0.9%
1986 S$0.13 B-7.78%
1985 S$0.14 B24.87%
1984 S$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.09 B-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.65 B 8.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.58 B-55.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$10.22 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA